The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB pathwayQing Li, Ming Xiang, Senlin Li et al.|Clinical Immunology|2022Cited by 26